Join the 200th Anniversary Celebration

Special Article

Release from Prison — A High Risk of Death for Former Inmates

Ingrid A. Binswanger, M.D., Marc F. Stern, M.D., Richard A. Deyo, M.D., Patrick J. Heagerty, Ph.D., Allen Cheadle, Ph.D., Joann G. Elmore, M.D., and Thomas D. Koepsell, M.D.

N Engl J Med 2007; 356:157-165January 11, 2007

Abstract

Background

The U.S. population of former prison inmates is large and growing. The period immediately after release may be challenging for former inmates and may involve substantial health risks. We studied the risk of death among former inmates soon after their release from Washington State prisons.

Methods

We conducted a retrospective cohort study of all inmates released from the Washington State Department of Corrections from July 1999 through December 2003. Prison records were linked to the National Death Index. Data for comparison with Washington State residents were obtained from the Wide-ranging OnLine Data for Epidemiologic Research system of the Centers for Disease Control and Prevention. Mortality rates among former inmates were compared with those among other state residents with the use of indirect standardization and adjustment for age, sex, and race.

Results

Of 30,237 released inmates, 443 died during a mean follow-up period of 1.9 years. The overall mortality rate was 777 deaths per 100,000 person-years. The adjusted risk of death among former inmates was 3.5 times that among other state residents (95% confidence interval [CI], 3.2 to 3.8). During the first 2 weeks after release, the risk of death among former inmates was 12.7 (95% CI, 9.2 to 17.4) times that among other state residents, with a markedly elevated relative risk of death from drug overdose (129; 95% CI, 89 to 186). The leading causes of death among former inmates were drug overdose, cardiovascular disease, homicide, and suicide.

Conclusions

Former prison inmates were at high risk for death after release from prison, particularly during the first 2 weeks. Interventions are necessary to reduce the risk of death after release from prison.

Media in This Article

Figure 1Mortality Rates among Former Inmates of the Washington State Department of Corrections during the Study Follow-up (Overall) and According to 2-Week Periods after Release from Prison.
Table 1Characteristics of 30,237 Persons Released from the Washington State Department of Corrections, July 1999–December 2003.
Article

At the end of 2004, more than 3% of adults in the United States were in jail, in prison, or on probation or parole.1 At the end of 2001, there were approximately 5.6 million adults who had ever been incarcerated in a state or federal prison,2 not including stays in local jails.

Prisoners' reentry — their return to the community from prison — can be stressful as former inmates try to obtain housing, reintegrate into their families and communities, find employment,3,4 and gain access to health care. Studies outside the United States have suggested a high mortality rate after the release from prison,5-11 but these findings have not been confirmed in the United States, and data on the causes of death are limited. European studies have suggested that mortality rates after release from prison were high among persons with a history of injection drug use.9,11 A history of prison release12 and prior arrests13 has been associated with fatal drug overdoses in Australia and with nonfatal drug overdoses in San Francisco. The first few weeks after release might be a time of high vulnerability to drug overdose. Former inmates may also be at risk for death from violence, unintentional injury, and a lapse in treatment of chronic health conditions.

Information about the risk and causes of death after release from prison could focus preventive efforts, improve transitional care, and guide policies to improve outcomes. Therefore, the objectives of this study were to determine the risk of death among persons released from Washington State prisons, compare the mortality rates among former inmates with those among other state residents, investigate whether the first 2 weeks after release were associated with an elevated risk of death, and describe the major causes of death.

Methods

Study Design

In this retrospective cohort study, we identified 30,636 persons who were released from the Washington State Department of Corrections between July 1, 1999, and December 31, 2003, from electronic records of the Department of Corrections. The Washington State prison system does not include jails, and it houses approximately 15,000 felony offenders sentenced to imprisonment for more than 1 year.

Of the 30,636 former inmates, 399 (1%) were excluded from the analysis for the following reasons: age was less 18 years at the time of release (45 persons), data on race were missing (20 persons), date of death reported by the National Death Index (NDI) for a match to a former inmate occurred before the person's release date but the person was not known to have died in prison (31 persons), the recorded date of release occurred before the date of admission to prison and two attempts to correct the inconsistency by contacting the Department of Corrections did not resolve it (155 persons), or death occurred while the inmate was on “extraordinary medical placement” (compassionate release) for grave illness before the official release date (5 persons). Six inmates who were granted extraordinary medical placement and survived until the end of their prison sentences were included in the analysis. The 143 inmates reported by the Department of Corrections to have died or to have been executed while incarcerated were excluded if the death occurred during the first or only admission to prison during the study period; otherwise, data on former inmates were censored as of the date of readmission to prison before death. The final sample consisted of 30,237 former inmates. The study was approved by the Veterans Affairs committee of the institutional review board of the University of Washington and the research review committee of the Washington State Department of Corrections, with a waiver of consent by the University of Washington Human Subjects Division.

Sources of Data

The Department of Corrections provided personal identifiers for all persons released from prison during the study period, including name, known aliases and nicknames, Social Security number, date and state of birth, sex, race, marital status, and dates of incarceration. Race or ethnic group is self-reported on entry into the Washington State Department of Corrections. A second source was the NDI, a computerized database of information abstracted by states from death certificates that indexes deaths in the 50 states, the District of Columbia, the Virgin Islands, and Puerto Rico.14 The NDI database provided potential matches of deaths for each record we submitted and a probabilistic score to determine which deaths were true matches to former inmates.15 If an alias was classified as a true match, the person was considered to have died. Given the sensitive nature of the study, we did not contact family members or friends to confirm death.

The Wide-ranging OnLine Data for Epidemiologic Research (WONDER) system of the Centers for Disease Control and Prevention (CDC), known as CDC WONDER,16 provided comparison data for Washington State residents in the form of death counts, population, and underlying causes of death according to age, sex, race, and year of death. The number of deaths in the state during 1999 was halved, because the study period began in mid-1999. Deaths and person-years of former inmates who died in Washington, according to the appropriate categories of age, sex, and race, were omitted, because these deaths were included in the total deaths reported in the CDC WONDER system.

Statistical Analysis

We calculated overall mortality rates (the number of deaths divided by the person-years at risk) and 95% confidence intervals (CIs). The time at risk was defined as the period between the release from prison and death, another incarceration, or the end of the study. For persons with repeated incarcerations during the study period, the time during a subsequent incarceration was excluded, whereas the time between the next release and death, another incarceration, or the end of the study was included. Data were censored as of December 31, 2003, or the date on which the inmate was reincarcerated, if the person remained in prison at the end of the study.

Using survival analysis, we examined the first 2 weeks and the three subsequent 2-week periods after release from prison. The relative risk of death was calculated by comparing mortality rates among former inmates to mortality rates among other Washington residents, with the use of indirect standardization,17 adjusting for age, sex, and race with Poisson regression. We used indirect standardization to compare mortality rates in the study cohort with those in the reference population of Washington State residents stratified according to age (in groups of 18 to 19 years, 20 to 24 years, 25 to 34 years, 35 to 44 years, 45 to 54 years, 55 to 64 years, 65 to 74 years, and 75 to 84 years), race (white, black, or other) and sex. Hispanic persons were categorized according to race, to correspond with the methods used in the CDC WONDER system. We examined potential interactions between release and age, release and sex, and release and race and used likelihood-ratio tests to detect significant differences in the fit of the models. The attributable-risk percentage is the relative risk minus 1, divided by the relative risk times 100. The number of expected deaths for the category of age, sex, or race was calculated by multiplying the category-specific state mortality rate by the number of person-years among former inmates in the category. The results were summed for those categories to obtain the total expected deaths.

Causes of death were classified broadly according to the underlying cause of death. Accidental poisoning and exposure to noxious substances was described as a drug overdose. We examined the frequency of use of specific codes of the International Classification of Disease, 10th Revision (ICD-10)18 in the list of multiple causes of death for each person provided in the NDI.15 We estimated mortality rates for incarcerated inmates, using the number of deaths reported as occurring in prison, confirmed in the NDI (139 deaths during the study period), divided by half the midyear prison population of the State of Washington in 1999 plus the total midyear prison population from 2000 to 2003, to approximate the number of inmate person-years. SAS software (version 9.1) and Intercooled Stata software (version 9.1) were used to perform the analyses.

Results

We followed 30,237 persons who had been released from the Washington State Department of Corrections for a total of 57,049 person-years (a total of 38,809 releases). The mean (±SD) age at release was 33.4±9.8 years (range, 18 to 84) (Table 1Table 1Characteristics of 30,237 Persons Released from the Washington State Department of Corrections, July 1999–December 2003.). The majority were non-Hispanic white (62%) and male (87%); 91% of those who reported that they were Hispanic also reported being white. The mean length of incarceration was 22.9±37.8 months; in many cases, incarceration had begun before the start of the study. Approximately a quarter of the study cohort was released more than once during follow-up (range, 1 to 10 releases).

Over a mean follow-up period of 1.9±3.1 years, 443 persons included in the analysis died. Of these, 253 persons died within 1 year after release from prison. Of deaths reported according to state, 379 occurred in Washington, 17 in Oregon, 17 in California, 4 in Texas, 3 in Idaho, and the remainder elsewhere. Overall, the mortality rate among released inmates (Figure 1Figure 1Mortality Rates among Former Inmates of the Washington State Department of Corrections during the Study Follow-up (Overall) and According to 2-Week Periods after Release from Prison.) was 777 deaths from all causes per 100,000 person-years (95% CI, 707 to 852). In contrast, the calculated mortality rate for Washington State residents of the same age, sex, and race as the former inmates was 223 deaths per 100,000 person-years. The mortality rate among former inmates was 3.5 times (95% CI, 3.2 to 3.8) that among state residents of the same age, sex, and race (Table 2Table 2Deaths and the Relative Risk (RR) of Death among Former Inmates of the Washington State Department of Corrections, as Compared with Other State Residents, Adjusted for Age, Sex, and Race.). The attributable-risk percentage was 71%, amounting to 316 excess deaths.

During the first 2 weeks after release, the rate of death from all causes among former inmates was 2589 per 100,000 person-years (95% CI, 1884 to 3558). The adjusted relative risk of death within the first 2 weeks after release was 12.7 times that among other state residents (95% CI, 9.2 to 17.4). If the mortality rate among former inmates were the same as that among other state residents of the same age, sex, and race, only 3 of the 38 deaths occurring within the first 2 weeks after release would have been expected. The mortality rate within the first week after release was even higher: 3661 per 100,000 person-years (95% CI, 2511 to 5399).

The adjusted relative risk of death among former inmates, as compared with other state residents, was significantly higher among women than among men (P=0.002) (Table 2). The relative risk of death among released inmates, as compared with other state residents, also varied according to age (P<0.001) and race (P=0.008).

The leading cause of death among former inmates was drug overdose (103 deaths) (Table 3Table 3Leading Causes of Death after Release from Prison.), representing nearly a quarter of all deaths. Of the 38 deaths occurring within 2 weeks after release, 27 were from overdoses. Within the first 2 weeks after release, the rate of death from overdose was 1840 per 100,000 person-years (95% CI, 1213 to 2677). The adjusted relative risk of death from overdose was 129 (95% CI, 89 to 186) among released inmates within 2 weeks after release, as compared with other state residents. Cocaine was involved in the largest number of deaths from overdose (50), followed by deaths involving use of psychostimulants, including methamphetamine (19), heroin (18), and methadone (18). Of deaths from overdose, 27 involved more than one substance (cocaine, psychostimulants, heroin, methadone, benzodiazepines, tricyclic antidepressants, or alcohol). Of 17 deaths from overdose of antidepressants, 13 involved tricyclic antidepressants.

The second leading cause of death was cardiovascular disease (56 deaths); of these deaths, 10 were caused by acute myocardial infarctions and 3 involved cocaine use. Homicide was the cause of the third highest absolute number of deaths (54) and the second highest number of excess deaths. Suicide, cancer, and motor vehicle accidents were also important causes of death. Deaths from cancer of the lung or bronchus represented nearly half of all deaths from cancer. Deaths from overdose, homicide, and suicide were more common among persons younger than 45 years, whereas deaths from cardiovascular disease and cancer were more common among those 45 years of age or older (Table 4Table 4Deaths among Former Inmates, According to Age Group at the Time of Most Recent Release and Cause of Death.). Firearms were involved in 54 deaths, including 36 homicides, 10 suicides, 5 legal interventions, and 1 accident.

One hundred thirty-nine inmates died while in prison during an estimated 69,230 person-years from July 1999 through December 2003. The overall mortality rate during incarceration was 201 deaths per 100,000 person-years (Table 5Table 5Mortality Rates among Former Inmates of Washington State Prisons and Crude Mortality Rates among Current Prison Inmates during the Study Period.). Among inmates, deaths from drug overdose occurred at a rate of 1.2, homicide at a rate of 5.0, and motor vehicle accidents at a rate of 1.2 deaths per 100,000 person-years, considerably less than the mortality rates for these causes after release. For nearly all causes of death, the rates among former inmates were substantially higher than those among inmates.

Discussion

During the first 2 weeks after release from the Washington State Department of Corrections, the risk of death among former inmates was 12.7 times that among Washington State residents of the same age, sex, and race. The sharply elevated risk immediately after release suggests that the reentry process contributes to excess mortality in this population.

Overall, we observed an increase by a factor of 3.5 in the risk of death among former inmates. Mortality rates did not return to the baseline of the general population of the same age, sex, and race even several weeks after release. Factors such as level of education, employment status, level of income, neighborhood of residence, and health insurance status may account in part for the difference between the mortality rates among former inmates and those among other state residents of the same age, sex, and race. National estimates suggest that state prison inmates have a lower level of education than does the general population.19 However, socioeconomic differences between former inmates and the general population are unlikely to account for all the observed variation in the relative risk of death during the 8 weeks after release from prison.

Our estimates for the study period showed that the risk of death was sharply higher after release than during incarceration, perhaps because there are fewer overdoses, homicides, or motor vehicle accidents during incarceration. In-prison mortality rates reported by the U.S. Bureau of Justice Statistics for 2001 and 2002 (244 deaths per 100,000 prisoners in state correctional facilities; 192 deaths per 100,000 Washington State prisoners) were also considerably lower than those among former inmates.20

Our comparisons were limited by the lack of specificity of the data in CDC WONDER on racial groups other than black or white, which may account for some of the interaction observed according to race. We may not have identified all deaths among former inmates, including deaths occurring outside the United States. Data on the Social Security numbers and names of former inmates may be more likely to be incorrect than data on other members of the population, but the personal identifiers of former inmates were likely to be as accurate as possible since these were provided by the criminal justice system. Ascertainment of known deaths may be better for men than for women and for whites than for blacks and persons of other races,21 but the NDI is currently the best available source for identifying deaths in the United States.21,22 Many types of personal identifiers and all known aliases for linkage improved our ability to ascertain deaths correctly.

We have identified important risks that former inmates must confront: drug overdose, cardiovascular disease, homicide, and suicide. A period of relative abstinence during incarceration may have led to diminished physiological tolerance to drugs, increasing the risk of overdose. The excess risk of homicide suggests that former inmates were exposed to considerable personal risk from violence. Firearms were involved in many deaths in this population after release. The risk of death from cardiovascular disease and lung cancer may be related to the high prevalence of tobacco use in populations in correctional institutions.23,24 A high prevalence of underlying mental illness and the psychological stress of reentry may have contributed to the excess risk of suicide. Persons with mental illness may have particular difficulty obtaining care and medications from community providers after the medications provided by prisons run out. Improved transitional planning for inmates with mental illness may help to reduce this risk.

We could not verify data from the Department of Corrections, nor could we be certain that deaths did not occur when an inmate was incarcerated in another correctional system within Washington State or elsewhere. Classification of the causes of death was subject to the limitations imposed by the use of data recorded in the NDI from death certificates. For instance, some suicides may have been misclassified as drug overdoses and some drug overdoses may have been misclassified as cardiovascular deaths. However, many suspected overdoses, suicides, and accidental deaths would have been coroners' cases and undergone investigation with toxicologic testing and autopsy, making our data at least as accurate as most standard reports on the cause of death provided by treating physicians.

Our study was based in a prison system in a single state in the United States, so we cannot be certain that the findings are generalizable to other correctional systems, states, or countries. U.S. prisons reported more than 600,000 releases in 2002.25 In addition, jails in which persons awaiting trial or serving short-term sentences for misdemeanors are detained had approximately 10 million releases in 1997 (7.2 million unique persons).26 If former jail inmates have an elevated risk of death similar to that of former inmates of Washington State prisons, the effect of the excess risk of death after release could be substantial.

Because a disproportionate number of black and Hispanic men interact with the criminal justice system, decreasing the risk of death after release may decrease disparities in health outcomes in this population overall. The age distribution in the categories of leading causes of death suggests that specific interventions might be targeted according to age. Interventions aimed at decreasing the risk of death could include planning for the transition from prison to the community, including use of halfway houses, work-release programs, drug-treatment programs, education about susceptibility to overdose after relative abstinence during incarceration, and preventive care to modify cardiac risk factors. Possible interventions after release include providing intensive case management during the period immediately following release and improving access to and continuity of medical and mental health care. In addition to possible reductions in mortality after release, there might be secondary benefits for society from such interventions, in the form of increased public safety.

Supported by a training program grant from Health Services Research and Development of the Department of Veterans Affairs and the Robert Wood Johnson Foundation, and a grant from the National Cancer Institute (1 K05 CA104699, to Dr. Elmore).

The opinions and conclusions are those of the authors and not necessarily those of the Department of Veterans Affairs, the Washington State Department of Corrections, or the Robert Wood Johnson Clinical Scholars Program.

No potential conflict of interest relevant to this article was reported.

We thank Allen Beck, Joseph O. Merrill, Lorna Rhodes, R. Peggy Smith, John F. Steiner, Katharine Bradley, and Theresa Hilliard for assistance with this project.

Source Information

From the Puget Sound Veterans Affairs Medical Center, Seattle (I.A.B., T.D.K.); the Departments of Medicine (I.A.B., R.A.D., J.G.E.), Health Services (I.A.B., R.A.D., A.C., T.D.K.), Biostatistics (P.J.H.), and Epidemiology (J.G.E., T.D.K.), University of Washington, Seattle; the Department of Medicine, University of Colorado at Denver and the Health Sciences Center, Denver (I.A.B.); and the Washington State Department of Corrections, Olympia (M.F.S.).

Address reprint requests to Dr. Binswanger at the Department of Medicine, Division of General Internal Medicine, University of Colorado at Denver and the Health Sciences Center, 4200 E. Ninth Ave., B180, Denver, CO 80262, or at .

References

References

  1. 1

    Bureau of Justice Statistics. Corrections statistics. Washington, DC: Department of Justice, 2006. (Accessed December 14, 2006, at http://www.ojp.usdoj.gov/bjs/correct.htm.)

  2. 2

    Idem. Criminal offenders statistics. Washington, DC: Department of Justice, 2005. (Accessed December 14, 2006, at http://www.ojp.usdoj.gov/bjs/crimoff.htm.)

  3. 3

    Iguchi MY, London JA, Forge NG, Hickman L, Fain T, Riehman K. Elements of well-being affected by criminalizing the drug user. Public Health Rep 2002;117:Suppl 1:S146-S150
    Web of Science | Medline

  4. 4

    Petersilia J. When prisoners come home: parole and prisoner reentry. New York: Oxford University Press, 2003.

  5. 5

    Jones R, Gruer L, Gilchrist G, Seymour A, Black M, Oliver J. Recent contact with health and social services by drug misusers in Glasgow who died of a fatal overdose in 1999. Addiction 2002;97:1517-1522
    CrossRef | Web of Science | Medline

  6. 6

    Stewart LM, Henderson CJ, Hobbs MS, Ridout SC, Knuiman MW. Risk of death in prisoners after release from jail. Aust N Z J Public Health 2004;28:32-36
    CrossRef | Web of Science | Medline

  7. 7

    Harding-Pink D. Mortality following release from prison. Med Sci Law 1990;30:12-16
    Web of Science | Medline

  8. 8

    Joukamaa M. The mortality of released Finnish prisoners: a 7 year follow-up study of the WATTU project. Forensic Sci Int 1998;96:11-19
    CrossRef | Web of Science | Medline

  9. 9

    Seaman SR, Brettle RP, Gore SM. Mortality from overdose among injecting drug users recently released from prison: database linkage study. BMJ 1998;316:426-428
    CrossRef | Web of Science | Medline

  10. 10

    Verger P, Rotily M, Prudhomme J, Bird S. High mortality rates among inmates during the year following their discharge from a French prison. J Forensic Sci 2003;48:614-616
    Web of Science | Medline

  11. 11

    Bird SM, Hutchinson SJ. Male drugs-related deaths in the fortnight after release from prison: Scotland, 1996-99. Addiction 2003;98:185-190
    CrossRef | Web of Science | Medline

  12. 12

    Darke S, Ross J, Zador D, Sunjic S. Heroin-related deaths in New South Wales, Australia, 1992-1996. Drug Alcohol Depend 2000;60:141-150
    CrossRef | Web of Science | Medline

  13. 13

    Seal KH, Kral AH, Gee L, et al. Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998-1999. Am J Public Health 2001;91:1842-1846
    CrossRef | Web of Science | Medline

  14. 14

    National Death Index user's manual. Hyattsville, MD: National Center for Health Statistics, 2000.

  15. 15

    National Death Index Plus: coded causes of death. Supplement to the National Death Index user's manual. Hyattsville, MD: National Center for Health Statistics, 1999.

  16. 16

    CDC WONDER: compressed mortality file. Atlanta: Centers for Disease Control and Prevention, 2005. (Accessed December 14, 2006, at http://wonder.cdc.gov/mortArchives.html.)

  17. 17

    Clayton D, Hills M. Statistical models in epidemiology. Oxford, England: Oxford University Press, 2002.

  18. 18

    International Statistical Classification of Diseases and Related Health Problems: 2006 version. Geneva: World Health Organization, 2006. (Accessed December 14, 2006, at http://www.who.int/classifications/apps/icd/icd10online/.)

  19. 19

    Harlow CW. Education and correctional populations: Bureau of Justice Statistics special report. Washington, DC: Department of Justice, 2003.

  20. 20

    Mumola C. Suicide and homicide in state prisons and local jails: Bureau of Justice Statistics special report. Washington, DC: Department of Justice, 2005.

  21. 21

    Wentworth DN, Neaton JD, Rasmussen WL. An evaluation of the Social Security Administration master beneficiary record file and the National Death Index in the ascertainment of vital status. Am J Public Health 1983;73:1270-1274
    CrossRef | Web of Science | Medline

  22. 22

    Boyle CA, Decoufle P. National sources of vital status information: extent of coverage and possible selectivity in reporting. Am J Epidemiol 1990;131:160-168
    Web of Science | Medline

  23. 23

    Cropsey K, Eldridge GD, Ladner T. Smoking among female prisoners: an ignored public health epidemic. Addict Behav 2004;29:425-431
    CrossRef | Web of Science | Medline

  24. 24

    Colsher PL, Wallace RB, Loeffelholz PL, Sales M. Health status of older male prisoners: a comprehensive survey. Am J Public Health 1992;82:881-884
    CrossRef | Web of Science | Medline

  25. 25

    Harrison PM, Karberg JC. Prison and jail inmates at midyear 2003: Bureau of Justice Statistics bulletin. Washington, DC: Department of Justice, 2004.

  26. 26

    Hammett TM, Harmon MP, Rhodes W. The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997. Am J Public Health 2002;92:1789-1794
    CrossRef | Web of Science | Medline

Citing Articles (122)

Citing Articles

  1. 1

    Stuart A. Kinner, M-J. Milloy, Evan Wood, Jiezhi Qi, Ruth Zhang, Thomas Kerr. (2012) Incidence and risk factors for non-fatal overdose among a cohort of recently incarcerated illicit drug users. Addictive Behaviors 37:6, 691-696
    CrossRef

  2. 2

    Roger T. Webb, Ping Qin, Hanne Stevens, Louis Appleby, Jenny Shaw, Preben Bo Mortensen. (2012) Combined influence of serious mental illness and criminal offending on suicide risk in younger adults. Social Psychiatry and Psychiatric Epidemiology
    CrossRef

  3. 3

    Michael G. Vaughn, Matt DeLisi, Kevin M. Beaver, Brian E. Perron, Arnelyn Abdon. (2012) Toward a criminal justice epidemiology: Behavioral and physical health of probationers and parolees in the United States. Journal of Criminal Justice 40:3, 165-173
    CrossRef

  4. 4

    Parya Saberi, Nikolai H. Caswell, Ross Jamison, Milton Estes, Jacqueline P. Tulsky. (2012) Directly Observed versus Self-administered Antiretroviral Therapies: Preference of HIV-Positive Jailed Inmates in San Francisco. Journal of Urban Health
    CrossRef

  5. 5

    S. Fazel, K. Seewald. (2012) Severe mental illness in 33 588 prisoners worldwide: systematic review and meta-regression analysis. The British Journal of Psychiatry 200:5, 364-373
    CrossRef

  6. 6

    (2012) Imprisonment and Infant Mortality. Social Problems 59:2, 228-257
    CrossRef

  7. 7

    Yih-Ing Hser, Liming Fu, Fei Wu, Jiang Du, Min Zhao. (2012) Pilot trial of a recovery management intervention for heroin addicts released from compulsory rehabilitation in China. Journal of Substance Abuse Treatment
    CrossRef

  8. 8

    Stacey C. Sigmon, Adam Bisaga, Edward V. Nunes, Patrick G. O'Connor, Thomas Kosten, George Woody. (2012) Opioid Detoxification and Naltrexone Induction Strategies: Recommendations for Clinical Practice. The American Journal of Drug and Alcohol Abuse1-13
    CrossRef

  9. 9

    April R. Smith, Jessica D. Ribeiro, Amy Mikolajewski, Jeanette Taylor, Thomas E. Joiner, William G. Iacono. (2012) An examination of environmental and genetic contributions to the determinants of suicidal behavior among male twins. Psychiatry Research
    CrossRef

  10. 10

    S. Lim, A. L. Seligson, F. M. Parvez, C. W. Luther, M. P. Mavinkurve, I. A. Binswanger, B. D. Kerker. (2012) Risks of Drug-Related Death, Suicide, and Homicide During the Immediate Post-Release Period Among People Released From New York City Jails, 2001-2005. American Journal of Epidemiology
    CrossRef

  11. 11

    Lisa A. Brenner, Sean M. Barnes. (2012) Facilitating Treatment Engagement During High-Risk Transition Periods: A Potential Suicide Prevention Strategy. American Journal of Public Healthe1-e3
    CrossRef

  12. 12

    Bruce G. Trigg, Samuel L. Dickman. (2012) Medication-Assisted Therapy for Opioid-Dependent Incarcerated Populations in New Mexico: Statewide Efforts to Increase Access. Substance Abuse 33:1, 76-84
    CrossRef

  13. 13

    Joshua D. Lee, Ellie Grossman, Andrea Truncali, John Rotrosen, Andrew Rosenblum, Stephen Magura, Marc N. Gourevitch. (2012) Buprenorphine-Naloxone Maintenance Following Release from Jail. Substance Abuse 33:1, 40-47
    CrossRef

  14. 14

    InSung Min, Dana Schonberg, Matthew Anderson. (2012) A Review of Primary Care Training Programs in Correctional Health for Physicians. Teaching and Learning in Medicine 24:1, 81-89
    CrossRef

  15. 15

    Christopher Wildeman. (2012) Imprisonment and (inequality in) population health. Social Science Research 41:1, 74-91
    CrossRef

  16. 16

    Ingrid A Binswanger, Carolyn Nowels, Karen F Corsi, Jason Glanz, Jeremy Long, Robert E Booth, John F Steiner. (2012) Return to drug use and overdose after release from prison: a qualitative study of risk and protective factors. Addiction Science & Clinical Practice 7:1, 3
    CrossRef

  17. 17

    , Josiah D. Rich, David A. Wohl, Curt G. Beckwith, Anne C. Spaulding, Nathaniel E. Lepp, Jacques Baillargeon, Adrian Gardner, Ann Avery, Frederick L. Altice, Sandra Springer. (2011) HIV-Related Research in Correctional Populations: Now is the Time. Current HIV/AIDS Reports 8:4, 288-296
    CrossRef

  18. 18

    Josiah D. Rich, Michelle McKenzie, Samuel Dickman, Jeffrey Bratberg, Joshua D. Lee, Robert P. Schwartz. (2011) An Adverse Reaction to Buprenorphine/Naloxone Induction in Prison. Addictive Disorders & Their Treatment 10:4, 199-200
    CrossRef

  19. 19

    Amy S.B. Bohnert, Kathryn M. Roeder, Mark A. Ilgen. (2011) Suicide attempts and overdoses among adults entering addictions treatment: Comparing correlates in a U.S. national study. Drug and Alcohol Dependence 119:1-2, 106-112
    CrossRef

  20. 20

    Ank E. Nijhawan, Alison K. DeLong, David D. Celentano, Robert S. Klein, Jack D. Sobel, Denise J. Jamieson, Susan Cu-Uvin. (2011) The Association Between Trichomonas Infection and Incarceration in HIV-Seropositive and At-Risk HIV-Seronegative Women. Sexually Transmitted Diseases 38:12, 1094-1100
    CrossRef

  21. 21

    Stephen Metraux, Nicholas Eng, Jay Bainbridge, Dennis P. Culhane. (2011) The Impact of Shelter Use and Housing Placement on Mortality Hazard for Unaccompanied Adults and Adults in Family Households Entering New York City Shelters: 1990–2002. Journal of Urban Health 88:6, 1091-1104
    CrossRef

  22. 22

    Karen L. Cropsey, Peter S. Lane, Galen J. Hale, Dorothy O. Jackson, C. Brendan Clark, Karen S. Ingersoll, M. Aminul Islam, Maxine L. Stitzer. (2011) Results of a pilot randomized controlled trial of buprenorphine for opioid dependent women in the criminal justice system. Drug and Alcohol Dependence 119:3, 172-178
    CrossRef

  23. 23

    Alex R. Piquero, David P. Farrington, Jonathan P. Shepherd, Katherine Auty. (2011) Offending and Early Death in the Cambridge Study in Delinquent Development. Justice Quarterly1-28
    CrossRef

  24. 24

    Alan Wayne Jones, Anita Holmgren, Johan Ahlner. (2011) Heroin poisoning deaths with 6-acetylmorphine in blood: demographics of the victims, previous drug-related offences, polydrug use, and free morphine concentrations in femoral blood. Forensic Toxicology
    CrossRef

  25. 25

    Nadine E. Chen, Jaimie P. Meyer, Ann K. Avery, Jeffrey Draine, Timothy P. Flanigan, Thomas Lincoln, Anne C. Spaulding, Sandra A. Springer, Frederick L. Altice. (2011) Adherence to HIV Treatment and Care Among Previously Homeless Jail Detainees. AIDS and Behavior
    CrossRef

  26. 26

    Michael S. Gordon, Timothy W. Kinlock, Patrice M. Miller. (2011) Medication-assisted Treatment Research with Criminal Justice Populations: Challenges of Implementation. Behavioral Sciences & the Law 29:6, 829-845
    CrossRef

  27. 27

    Ali Shabahang Saber-Tehrani, Sandra A. Springer, Jingjun Qiu, Maua Herme, Jeffrey Wickersham, Frederick L. Altice. (2011) Rationale, study design and sample characteristics of a randomized controlled trial of directly administered antiretroviral therapy for HIV-infected prisoners transitioning to the community — A potential conduit to improved HIV treatment outcomes. Contemporary Clinical Trials
    CrossRef

  28. 28

    Paul P. Christopher, Philip J. Candilis, Josiah D. Rich, Charles W. Lidz. (2011) An Empirical Ethics Agenda for Psychiatric Research Involving Prisoners. AJOB Primary Research 2:4, 18-25
    CrossRef

  29. 29

    Cyrus Ahalt, Ingrid A. Binswanger, Michael Steinman, Jacqueline Tulsky, Brie A. Williams. (2011) Confined to Ignorance: The Absence of Prisoner Information from Nationally Representative Health Data Sets. Journal of General Internal Medicine
    CrossRef

  30. 30

    Ingrid A. Binswanger, Nicole Redmond, John F. Steiner, LeRoi S. Hicks. (2011) Health Disparities and the Criminal Justice System: An Agenda for Further Research and Action. Journal of Urban Health
    CrossRef

  31. 31

    S. A. Springer, A. C. Spaulding, J. P. Meyer, F. L. Altice. (2011) Public Health Implications for Adequate Transitional Care for HIV-Infected Prisoners: Five Essential Components. Clinical Infectious Diseases 53:5, 469-479
    CrossRef

  32. 32

    Jesenia M. Pizarro, Kristen M. Zgoba, Wesley G. Jennings. (2011) Assessing the interaction between offender and victim criminal lifestyles & homicide type. Journal of Criminal Justice 39:5, 367-377
    CrossRef

  33. 33

    Timothy P. Condon, Petra Jacobs, Betty Tai, Denise Pintello, Lucinda Miner, Jennifer C. Elcano. (2011) Patient Relapse in the Context of Drug Abuse Treatment. Journal of Addiction Medicine 5:3, 157-162
    CrossRef

  34. 34

    TIMOTHY W. KINLOCK. (2011) Commentary on Huang et al. (2011): New questions and directions for future research emanating from an evaluation of the effectiveness of a harm reduction program. Addiction 106:8, 1446-1447
    CrossRef

  35. 35

    Roland M. Jones, Heidi Hales, Martin Butwell, Mike Ferriter, Pamela J. Taylor. (2011) Suicide in high security hospital patients. Social Psychiatry and Psychiatric Epidemiology 46:8, 723-731
    CrossRef

  36. 36

    Jennifer Adams, Carolyn Nowels, Karen Corsi, Jeremy Long, John F Steiner, Ingrid A Binswanger. (2011) HIV Risk After Release From Prison: A Qualitative Study of Former Inmates. JAIDS Journal of Acquired Immune Deficiency Syndromes 57:5, 429-434
    CrossRef

  37. 37

    Yen-Fang Huang, Hsu-Sung Kuo, Chin-Yin Lew-Ting, Fang Tian, Chin-Hui Yang, Tzu-I. Tsai, Stephen J. Gange, Kenrad E. Nelson. (2011) Mortality among a cohort of drug users after their release from prison: an evaluation of the effectiveness of a harm reduction program in Taiwan. Addiction 106:8, 1437-1445
    CrossRef

  38. 38

    James A. Swartz. (2011) Chronic Medical Conditions among Jail Detainees in Residential Psychiatric Treatment: A Latent Class Analysis. Journal of Urban Health 88:4, 700-717
    CrossRef

  39. 39

    Ingrid A. Binswanger, Patrick J. Blatchford, Rebecca G. Lindsay, Marc F. Stern. (2011) Risk factors for all-cause, overdose and early deaths after release from prison in Washington state. Drug and Alcohol Dependence 117:1, 1-6
    CrossRef

  40. 40

    Chethan Bachireddy, Alexander R. Bazazi, Ravi Kavasery, Sumathi Govindasamy, Adeeba Kamarulzaman, Frederick L. Altice. (2011) Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: Implications for secondary prevention. Drug and Alcohol Dependence 116:1-3, 151-157
    CrossRef

  41. 41

    Michele Staton-Tindall, Erin McNees, Carl Leukefeld, Robert Walker, Carrie Oser, Jamieson Duvall, LaDonna Thompson, Kevin Pangburn. (2011) Treatment Utilization Among Metropolitan and Nonmetropolitan Participants of Corrections-Based Substance Abuse Programs Reentering the Community. Journal of Social Service Research 37:4, 379-389
    CrossRef

  42. 42

    Ingrid A. Binswanger, Carolyn Nowels, Karen F. Corsi, Jeremy Long, Robert E. Booth, Jean Kutner, John F. Steiner. (2011) “From the prison door right to the sidewalk, everything went downhill,” A qualitative study of the health experiences of recently released inmates. International Journal of Law and Psychiatry 34:4, 249-255
    CrossRef

  43. 43

    Rich, Josiah D., Wakeman, Sarah E., Dickman, Samuel L., . (2011) Medicine and the Epidemic of Incarceration in the United States. New England Journal of Medicine 364:22, 2081-2083
    Full Text

  44. 44

    Tracy D. Gunter, John T. Chibnall, Sandra K. Antoniak, Robert A. Philibert, Nancy Hollenbeck. (2011) Predictors of suicidal ideation, suicide attempts, and self-harm without lethal intent in a community corrections sample. Journal of Criminal Justice 39:3, 238-245
    CrossRef

  45. 45

    Brandon DL Marshall, M-J Milloy, Evan Wood, Julio SG Montaner, Thomas Kerr. (2011) Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study. The Lancet 377:9775, 1429-1437
    CrossRef

  46. 46

    C. Wildeman. (2011) Invited Commentary: (Mass) Imprisonment and (Inequities in) Health. American Journal of Epidemiology 173:5, 488-491
    CrossRef

  47. 47

    Jason Schnittker, Michael Massoglia, Christopher Uggen. (2011) INCARCERATION AND THE HEALTH OF THE AFRICAN AMERICAN COMMUNITY. Du Bois Review: Social Science Research on Race 8:01, 133-141
    CrossRef

  48. 48

    Seena Fazel, Jacques Baillargeon. (2011) The health of prisoners. The Lancet 377:9769, 956-965
    CrossRef

  49. 49

    A. C. Spaulding, R. M. Seals, V. A. McCallum, S. D. Perez, A. K. Brzozowski, N. K. Steenland. (2011) Prisoner Survival Inside and Outside of the Institution: Implications for Health-Care Planning. American Journal of Epidemiology 173:5, 479-487
    CrossRef

  50. 50

    Lindsay M. Jenkins, Caleb J. Banta-Green, Charles Maynard, Susan Kingston, Michael Hanrahan, Joseph O. Merrill, Phillip O. Coffin. (2011) Risk Factors for Nonfatal Overdose at Seattle-Area Syringe Exchanges. Journal of Urban Health 88:1, 118-128
    CrossRef

  51. 51

    Melissa R. Pfeiffer, David B. Hanna, Elizabeth M. Begier, Kent A. Sepkowitz, Regina Zimmerman, Judith E. Sackoff. (2011) Excess Mortality Among Injection Drug Users With AIDS, New York City (1999–2004). Substance Use & Misuse 46:2-3, 245-253
    CrossRef

  52. 52

    Amy S.B. Bohnert, Arijit Nandi, Melissa Tracy, Magdalena Cerdá, Kenneth J. Tardiff, David Vlahov, Sandro Galea. (2011) Policing and risk of overdose mortality in urban neighborhoods. Drug and Alcohol Dependence 113:1, 62-68
    CrossRef

  53. 53

    Carmelo GA Nobile, Domenico Flotta, Gaetano Nicotera, Claudia Pileggi, Italo F Angelillo. (2011) Self-reported health status and access to health services in a sample of prisoners in Italy. BMC Public Health 11:1, 529
    CrossRef

  54. 54

    Robyn L Richmond, Kay A Wilhelm, Devon Indig, Tony G Butler, Vicki A Archer, Alex D Wodak. (2011) Cardiovascular risk among Aboriginal and non-Aboriginal smoking male prisoners: inequalities compared to the wider community. BMC Public Health 11:1, 783
    CrossRef

  55. 55

    Jaimie P. Meyer, Nadine E. Chen, Sandra A. Springer. (2011) HIV Treatment in the Criminal Justice System: Critical Knowledge and Intervention Gaps. AIDS Research and Treatment 2011, 1-10
    CrossRef

  56. 56

    Sandra A. Springer, Marwan M. Azar, Frederick L. Altice. (2011) HIV, alcohol dependence, and the criminal justice system: a review and call for evidence-based treatment for released prisoners. The American Journal of Drug and Alcohol Abuse 37:1, 12-21
    CrossRef

  57. 57

    Jessica Y Andrews, Simon Forsyth, Jessica Wade, Stuart A Kinner. (2011) Sensitivity of a national coronial database for monitoring unnatural deaths among ex-prisoners in Australia. BMC Research Notes 4:1, 450
    CrossRef

  58. 58

    Gary A. Zarkin, Alexander J. Cowell, Katherine A. Hicks, Michael J. Mills, Steven Belenko, Laura J. Dunlap, Kimberly A. Houser, Vince Keyes. (2011) Benefits and costs of substance abuse treatment programs for state prison inmates: results from a lifetime simulation model. Health Economicsn/a-n/a
    CrossRef

  59. 59

    M.-J. Milloy, Evan Wood, Elisa Lloyd-Smith, Eric Grafstein, Mark Tyndall, Julio Montaner, Thomas Kerr. (2010) Recent Incarceration Linked to Cutaneous Injection-Related Infections Among Active Injection Drug Users in a Canadian Setting. Journal of Community Health 35:6, 660-666
    CrossRef

  60. 60

    M-J. Milloy, Evan Wood, Charlotte Reading, Daniel Kane, Julio Montaner, Thomas Kerr. (2010) Elevated overdose mortality rates among First Nations individuals in a Canadian setting: a population-based analysis. Addiction 105:11, 1962-1970
    CrossRef

  61. 61

    Brie A. Williams, James McGuire, Rebecca G. Lindsay, Jacques Baillargeon, Irena Stijacic Cenzer, Sei J. Lee, Margot Kushel. (2010) Coming Home: Health Status and Homelessness Risk of Older Pre-release Prisoners. Journal of General Internal Medicine 25:10, 1038-1044
    CrossRef

  62. 62

    M-J Milloy, Evan Wood. (2010) HIV treatment in the criminal justice system. HIV Therapy 4:5, 519-522
    CrossRef

  63. 63

    Elizabeth L. C. Merrall, Azar Kariminia, Ingrid A. Binswanger, Michael S. Hobbs, Michael Farrell, John Marsden, Sharon J. Hutchinson, Sheila M. Bird. (2010) Meta-analysis of drug-related deaths soon after release from prison. Addiction 105:9, 1545-1554
    CrossRef

  64. 64

    STUART A. KINNER. (2010) Commentary on Merrall et al. (2010): Understanding mortality and health outcomes for ex-prisoners - first steps on a long road. Addiction 105:9, 1555-1556
    CrossRef

  65. 65

    M.- J. S. Milloy, T. Kerr, R. Zhang, M. Tyndall, J. Montaner, E. Wood. (2010) Inability to access addiction treatment and risk of HIV infection among injection drug users recruited from a supervised injection facility. Journal of Public Health 32:3, 342-349
    CrossRef

  66. 66

    Joel M. Silberberg, Milap A. Nowrangi, Geetha Nampiaparampil. 2010. Crime, Substance Use, and Mental Illness. , 15-30.
    CrossRef

  67. 67

    Emily A. Wang, Brent A. Moore, Lynn E. Sullivan, David A. Fiellin. (2010) Effect of Incarceration History on Outcomes of Primary Care Office-based Buprenorphine/Naloxone. Journal of General Internal Medicine 25:7, 670-674
    CrossRef

  68. 68

    AMY NUNN, NICKOLAS ZALLER, SAMUEL DICKMAN, ANK NIJHAWAN, JOSIAH D. RICH. (2010) IMPROVING ACCESS TO OPIATE ADDICTION TREATMENT FOR PRISONERS. Addiction 105:7, 1312-1313
    CrossRef

  69. 69

    Sandra Ann Springer, Shu Chen, Frederick L. Altice. (2010) Improved HIV and Substance Abuse Treatment Outcomes for Released HIV-Infected Prisoners: The Impact of Buprenorphine Treatment. Journal of Urban Health 87:4, 592-602
    CrossRef

  70. 70

    Sarah E Wakeman, Josiah D Rich. (2010) HIV treatment in US prisons. HIV Therapy 4:4, 505-510
    CrossRef

  71. 71

    Robin A. Pollini, Remedios Lozada, Manuel Gallardo, Perth Rosen, Alicia Vera, Armando Macias, Lawrence A. Palinkas, Steffanie A. Strathdee. (2010) Barriers to Pharmacy-Based Syringe Purchase Among Injection Drug Users in Tijuana, Mexico: A Mixed Methods Study. AIDS and Behavior 14:3, 679-687
    CrossRef

  72. 72

    Kristy A. Martire, Sarah Larney. (2010) An estimate of the number of inmate separations from Australian prisons 2000/01 and 2005/06. Australian and New Zealand Journal of Public Health 34:3, 255-257
    CrossRef

  73. 73

    Matthew W. Epperson, Maria R. Khan, Daniel P. Miller, Brian E. Perron, Nabila El-Bassel, Louisa Gilbert. (2010) Assessing criminal justice involvement as an indicator of human immunodeficiency virus risk among women in methadone treatment. Journal of Substance Abuse Treatment 38:4, 375-383
    CrossRef

  74. 74

    Steven J. Sandage. (2010) Intergenerational Suicide and Family Dynamics: A Hermeneutic Phenomenological Case Study. Contemporary Family Therapy 32:2, 209-227
    CrossRef

  75. 75

    Amy J. Harzke, Jacques G. Baillargeon, Sandi L. Pruitt, John S. Pulvino, David P. Paar, Michael F. Kelley. (2010) Prevalence of Chronic Medical Conditions among Inmates in the Texas Prison System. Journal of Urban Health 87:3, 486-503
    CrossRef

  76. 76

    Chuan-Yu Chen, Pei-Ning Wu, Lien-Wen Su, Yiing-Jenq Chou, Keh-Ming Lin. (2010) Three-year mortality and predictors after release: a longitudinal study of the first-time drug offenders in Taiwan. Addiction 105:5, 920-927
    CrossRef

  77. 77

    D. Pratt, L. Appleby, M. Piper, R. Webb, J. Shaw. (2010) Suicide in recently released prisoners: a case-control study. Psychological Medicine 40:05, 827
    CrossRef

  78. 78

    Michael D. Stein, Celeste M. Caviness, Bradley J. Anderson, Meg Hebert, Jennifer G. Clarke. (2010) A brief alcohol intervention for hazardously drinking incarcerated women. Addiction 105:3, 466-475
    CrossRef

  79. 79

    Ingrid A. Binswanger, Joseph O. Merrill, Patrick M. Krueger, Mary C. White, Robert E. Booth, Joann G. Elmore. (2010) Gender Differences in Chronic Medical, Psychiatric, and Substance-Dependence Disorders Among Jail Inmates. American Journal of Public Health 100:3, 476-482
    CrossRef

  80. 80

    Timothy W. Kinlock, Michael S. Gordon, Robert P. Schwartz, Terrence T. Fitzgerald. (2010) Developing and Implementing a New Prison-Based Buprenorphine Treatment Program. Journal of Offender Rehabilitation 49:2, 91-109
    CrossRef

  81. 81

    (2010) Commentary on Larney (2010): A call to actionâopioid substitution therapy as a conduit to routine care and primary prevention of HIV transmission among opioid-dependent prisoners. Addiction 105:2, 224-225
    CrossRef

  82. 82

    Joseph Tucker, Xin Ren, Flora Sapio. (2010) Incarcerated sex workers and HIV prevention in China: Social suffering and social justice countermeasures. Social Science & Medicine 70:1, 121-129
    CrossRef

  83. 83

    Einar Ødegård, Ellen J. Amundsen, Knut Boe Kielland, Ragnar Kristoffersen. (2010) The contribution of imprisonment and release to fatal overdose among a cohort of Norwegian drug abusers. Addiction Research & Theory 18:1, 51-58
    CrossRef

  84. 84

    Philipp Paul Lobmaier, Nikolaj Kunøe, Helge Waal. (2010) Treatment research in prison: Problems and solutions in a randomized trial. Addiction Research & Theory 18:1, 1-13
    CrossRef

  85. 85

    Stephen A. Colucciello. 2010. Suicide. , 1463-1471.
    CrossRef

  86. 86

    Katarina Swahnberg, Barbro Wijma. (2009) The Body a ‘Double-Edged Sword’? A Qualitative Study on Swedish Female Prisoners' Relationship toward Their Bodies. Journal of Scandinavian Studies in Criminology and Crime Prevention 10:2, 161-177
    CrossRef

  87. 87

    Becky Pettit, Christopher J. Lyons. (2009) Incarceration and the Legitimate Labor Market: Examining Age-Graded Effects on Employment and Wages. Law & Society Review 43:4, 725-756
    CrossRef

  88. 88

    Kelly Bedard, H. E. Frech. (2009) Prison health care: is contracting out healthy?. Health Economics 18:11, 1248-1260
    CrossRef

  89. 89

    Amy Nunn, Nickolas Zaller, Samuel Dickman, Catherine Trimbur, Ank Nijhawan, Josiah D. Rich. (2009) Methadone and buprenorphine prescribing and referral practices in US prison systems: Results from a Nationwide Survey. Drug and Alcohol Dependence 105:1-2, 83-88
    CrossRef

  90. 90

    Timothy W. Kinlock, Michael S. Gordon, Robert P. Schwartz, Terrence T. Fitzgerald, Kevin E. O'Grady. (2009) A randomized clinical trial of methadone maintenance for prisoners: Results at 12 months postrelease. Journal of Substance Abuse Treatment 37:3, 277-285
    CrossRef

  91. 91

    Faye S. Taxman, Craig E. Henderson, Steven Belenko. (2009) Organizational context, systems change, and adopting treatment delivery systems in the criminal justice system. Drug and Alcohol Dependence 103, S1-S6
    CrossRef

  92. 92

    (2009) [Commentary] DATABASE LINKAGE: OUTSIDE REFLECTIONS ON HEALTH CARE INSIDE PRISONS. Addiction 104:7, 1241-1242
    CrossRef

  93. 93

    Carrie Pettus-Davis, Anna M. Scheyett, Danielle Hailey, Carol Golin, David Wohl. (2009) From the “Streets” To “Normal Life”: Assessing the Role of Social Support in Release Planning for HIV-Positive and Substance-Involved Prisoners. Journal of Offender Rehabilitation 48:5, 367-387
    CrossRef

  94. 94

    Sarah E. Wakeman, Margaret E. McKinney, Josiah D. Rich. (2009) Filling the Gap: The Importance of Medicaid Continuity for Former Inmates. Journal of General Internal Medicine 24:7, 860-862
    CrossRef

  95. 95

    Noga Shalev. (2009) From Public to Private Care The Historical Trajectory of Medical Services in a New York City Jail. American Journal of Public Health 99:6, 988-995
    CrossRef

  96. 96

    Kristen Clements-Nolle, Matthew Wolden, Jessey Bargmann-Losche. (2009) Childhood Trauma and Risk for Past and Future Suicide Attempts among Women in Prison. Women's Health Issues 19:3, 185-192
    CrossRef

  97. 97

    Sarah E. Wakeman, Sarah E. Bowman, Michelle McKenzie, Alexandra Jeronimo, Josiah D. Rich. (2009) Preventing Death Among the Recently Incarcerated: An Argument for Naloxone Prescription Before Release. Journal of Addictive Diseases 28:2, 124-129
    CrossRef

  98. 98

    Andrew P. Wilper, Steffie Woolhandler, J. Wesley Boyd, Karen E. Lasser, Danny McCormick, David H. Bor, David U. Himmelstein. (2009) The Health and Health Care of US Prisoners: Results of a Nationwide Survey. American Journal of Public Health 99:4, 666-672
    CrossRef

  99. 99

    M. Douglas Anglin, Bradley T. Conner, Jeffrey J. Annon, Douglas Longshore. (2009) Longitudinal Effects of LAAM and Methadone Maintenance on Heroin Addict Behavior. The Journal of Behavioral Health Services & Research 36:2, 267-282
    CrossRef

  100. 100

    Benjamin Hickler, Colette L. Auerswald. (2009) The worlds of homeless white and African American youth in San Francisco, California: A cultural epidemiological comparison. Social Science & Medicine 68:5, 824-831
    CrossRef

  101. 101

    Emma Plugge, Patricia Yudkin, Nicola Douglas. (2009) Changes in women's use of illicit drugs following imprisonment. Addiction 104:2, 215-222
    CrossRef

  102. 102

    Stephen Magura, Joshua D. Lee, Jason Hershberger, Herman Joseph, Lisa Marsch, Carol Shropshire, Andrew Rosenblum. (2009) Buprenorphine and methadone maintenance in jail and post-release: A randomized clinical trial. Drug and Alcohol Dependence 99:1-3, 222-230
    CrossRef

  103. 103

    M.-J. Milloy, E. Wood, M. Tyndall, C. Lai, J. Montaner, T. Kerr. (2009) Recent incarceration and use of a supervised injection facility in Vancouver, Canada. Addiction Research & Theory 17:5, 538-545
    CrossRef

  104. 104

    J.A. Stockman. (2009) Recreational All-Terrain Vehicle Injuries Among Children: An 11-Year Review of a Central Kentucky Level I Pediatric Trauma Center Database. Yearbook of Pediatrics 2009, 350-352
    CrossRef

  105. 105

    David L. Rosen, Victor J. Schoenbach, David A. Wohl. (2008) All-Cause and Cause-Specific Mortality Among Men Released From State Prison, 1980–2005. American Journal of Public Health 98:12, 2278-2284
    CrossRef

  106. 106

    A. Fernandez, G. Noël. (2008) Précarité sociale, cancer et vulnérabilité psychique, lien direct ou indirect ?. Psycho-Oncologie 2:4, 250-265
    CrossRef

  107. 107

    Emily A. Wang, Mary C. White, Ross Jamison, Joe Goldenson, Milton Estes, Jacqueline P. Tulsky. (2008) Discharge Planning and Continuity of Health Care: Findings From the San Francisco County Jail. American Journal of Public Health 98:12, 2182-2184
    CrossRef

  108. 108

    Hannah L. F. Cooper, Joanne E. Brady, Samuel R. Friedman, Barbara Tempalski, Karla Gostnell, Peter L. Flom. (2008) Estimating the Prevalence of Injection Drug Use among Black and White Adults in Large U.S. Metropolitan Areas over Time (1992–2002): Estimation Methods and Prevalence Trends. Journal of Urban Health 85:6, 826-856
    CrossRef

  109. 109

    Jennifer A. Tan, Tom A. Joseph, Sammy Saab. (2008) Treating hepatitis C in the prison population is cost-saving. Hepatology 48:5, 1387-1395
    CrossRef

  110. 110

    Daniel Werb, Evan Wood, Will Small, Steffanie Strathdee, Kathy Li, Julio Montaner, Thomas Kerr. (2008) Effects of police confiscation of illicit drugs and syringes among injection drug users in Vancouver. International Journal of Drug Policy 19:4, 332-338
    CrossRef

  111. 111

    Mary C. White, Elizabeth Marlow, Jacqueline P. Tulsky, Milton Estes, Enrique Menendez. (2008) Recidivism in HIV-Infected Incarcerated Adults: Influence of the Lack of a High School Education. Journal of Urban Health 85:4, 585-595
    CrossRef

  112. 112

    (2008) [Commentary] FROM THE CAN TO THE COFFIN: DEATHS AMONG RECENTLY RELEASED PRISONERS. Addiction 103:2, 256-257
    CrossRef

  113. 113

    Michael Farrell, John Marsden. (2008) Acute risk of drug-related death among newly released prisoners in England and Wales. Addiction 103:2, 251-255
    CrossRef

  114. 114

    Leo Beletsky, Corey S. Davis, Evan Anderson, Scott Burris. (2008) The Law (and Politics) of Safe Injection Facilities in the United States. American Journal of Public Health 98:2, 231-237
    CrossRef

  115. 115

    Megan Comfort. (2007) Punishment Beyond the Legal Offender. Annual Review of Law and Social Science 3:1, 271-296
    CrossRef

  116. 116

    Timothy W. Kinlock, Michael S. Gordon, Robert P. Schwartz, Kevin O’Grady, Terrence T. Fitzgerald, Monique Wilson. (2007) A randomized clinical trial of methadone maintenance for prisoners: Results at 1-month post-release. Drug and Alcohol Dependence 91:2-3, 220-227
    CrossRef

  117. 117

    Christy A. Visher. (2007) Returning Home: Emerging Findings and Policy Lessons about Prisoner Reentry. Federal Sentencing Reporter 20:1, 93-102
    CrossRef

  118. 118

    Beth A. Colgan. (2007) The Presidential Politics of Prisoner Reentry Reform. Federal Sentencing Reporter 20:1, 110-123
    CrossRef

  119. 119

    Azar Kariminia, Matthew G. Law, Tony G. Butler, Simon P. Corben, Michael H. Levy, John M. Kaldor, Luke Grant. (2007) Factors associated with mortality in a cohort of Australian prisoners. European Journal of Epidemiology 22:7, 417-428
    CrossRef

  120. 120

    (2007) Mortality after Release from Prison. New England Journal of Medicine 356:17, 1785-1787
    Full Text

  121. 121

    Gibney, Eric M., . (2007) Concurrent Sentences — Dialysis in the State Penitentiary. New England Journal of Medicine 356:2, 108-110
    Full Text

  122. 122

    Okie, Susan, . (2007) Sex, Drugs, Prisons, and HIV. New England Journal of Medicine 356:2, 105-108
    Full Text

Letters